My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 90

    1.

    Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers.

    Cooper CL, Ahluwalia NK, Efler SM, Vollmer J, Krieg AM, Davis HL.

    J Immune Based Ther Vaccines. 2008 Jun 9;6:3.PMID: 18541039 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.

    Libri NA, Barker SJ, Rosenberg WM, Semper AE.

    J Viral Hepat. 2009 May;16(5):315-24. Epub 2009 Feb 24.PMID: 19243499 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    3.

    [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer]

    Ren T, Cai YY, Liang YJ, Jin ML, Guo ZL, Tao MF, He X.

    Zhonghua Yi Xue Za Zhi. 2008 Apr 29;88(17):1168-72. Chinese. PMID: 18844109 [PubMed - indexed for MEDLINE]Related citations

    4.

    Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells.

    Booth JS, Nichani AK, Benjamin P, Dar A, Krieg AM, Babiuk LA, Mutwiri GK.

    Vet Immunol Immunopathol. 2007 Jan 15;115(1-2):24-34. Epub 2006 Sep 26.PMID: 17067685 [PubMed - indexed for MEDLINE]Related citations

    5.

    Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1.

    Gondois-Rey F, Dental C, Halfon P, Baumert TF, Olive D, Hirsch I.

    PLoS One. 2009;4(2):e4319. Epub 2009 Feb 2.PMID: 19183807 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    6.

    Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.

    Pham TN, Mercer SE, Michalak TI.

    J Viral Hepat. 2009 Aug;16(8):547-56. Epub 2009 Feb 8.PMID: 19215578 [PubMed - indexed for MEDLINE]Related citations

    7.

    Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression.

    Dar A, Nichani AK, Benjamin P, Lai K, Soita H, Krieg AM, Potter A, Babiuk LA, Mutwiri GK.

    Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):324-36. Epub 2008 Feb 17.PMID: 18367252 [PubMed - indexed for MEDLINE]Related citations

    8.

    Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide.

    Mena A, Nichani AK, Popowych Y, Ioannou XP, Godson DL, Mutwiri GK, Hecker R, Babiuk LA, Griebel P.

    Oligonucleotides. 2003;13(4):245-59.PMID: 15000839 [PubMed - indexed for MEDLINE]Related citations

    9.

    [The immunostimulatory study on peripheral blood mononuclear cell and CD4+ T lymphocyte of HBV infections that were activated by CpG oligonucleotide]

    Xiang TX, Wu XP, Li MH, Xie Y, Huang JG, Ma XY, Li XQ, Zhang B.

    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Aug;22(4):278-80. Chinese. PMID: 19105343 [PubMed - indexed for MEDLINE]Related citations

    10.

    Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals.

    Barrett L, Gallant M, Howley C, Bowmer MI, Hirsch G, Peltekian K, Grant M.

    BMC Immunol. 2008 Jun 13;9:28.PMID: 18554409 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    11.

    Effect of interferon-alpha, ribavirin, pentoxifylline, and interleukin-18 antibody on hepatitis C sera-stimulated hepatic stellate cell proliferation.

    Khan F, Peltekian KM, Peterson TC.

    J Interferon Cytokine Res. 2008 Nov;28(11):643-51.PMID: 18844579 [PubMed - indexed for MEDLINE]Related citations

    12.

    Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys.

    Park SH, Lee SR, Hyun BH, Kim BM, Sung YC.

    Vaccine. 2008 Jul 29;26(32):3978-83. Epub 2008 Jun 2.PMID: 18556097 [PubMed - indexed for MEDLINE]Related citations

    13.

    [Interferon alpha, gamma, omega before and during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin]

    Bolewska B, Czajka A, Moczko J, Juszczyk J.

    Przegl Epidemiol. 2007;61(4):755-63. Polish. PMID: 18572508 [PubMed - indexed for MEDLINE]Related citations

    14.

    Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.

    Vispo E, Barreiro P, Rodriguez-Nóvoa S, Morello J, Labarga P, Martín-Carbonero L, Maida I, García-Gascó P, Soriano V.

    Antivir Ther. 2008;13(4):511-7.PMID: 18672529 [PubMed - indexed for MEDLINE]Related citations

    15.

    Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha induction.

    Yu D, Putta MR, Bhagat L, Dai M, Wang D, Trombino AF, Sullivan T, Kandimalla ER, Agrawal S.

    Antimicrob Agents Chemother. 2008 Dec;52(12):4320-5. Epub 2008 Oct 13.PMID: 18852281 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    16.

    Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirin.

    Oze T, Hiramatsu N, Yakushijin T, Kurokawa M, Igura T, Mochizuki K, Imanaka K, Yamada A, Oshita M, Hagiwara H, Mita E, Ito T, Inui Y, Hijioka T, Tamura S, Yoshihara H, Hayashi E, Inoue A, Imai Y, Kato M, Yoshida Y, Tatsumi T, Ohkawa K, Kiso S, Kanto T, Kasahara A, Takehara T, Hayashi N.

    J Viral Hepat. 2009 Aug;16(8):578-85. Epub 2009 Jun 22.PMID: 19552663 [PubMed - indexed for MEDLINE]Related citations

    17.

    Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.

    Vincent IE, Lucifora J, Durantel D, Hantz O, Chemin I, Zoulim F, Trepo C.

    Antivir Ther. 2009;14(1):131-5.PMID: 19320247 [PubMed - indexed for MEDLINE]Related citations

    18.

    Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cells.

    Sidorkiewicz M, Józwiak B, Durys B, Majda-Stanislawska E, Piekarska A, Kosciuk N, Ciechowicz J, Majewska E, Bartkowiak J.

    Virus Res. 2009 Oct;145(1):141-4. Epub 2009 Jun 18.PMID: 19540284 [PubMed - indexed for MEDLINE]Related citations

    19.

    Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.

    Laguno M, Cifuentes C, Murillas J, Veloso S, Larrousse M, Payeras A, Bonet L, Vidal F, Milinkovic A, Bassa A, Villalonga C, Pérez I, Tural C, Martínez-Rebollar M, Calvo M, Blanco JL, Martínez E, Sánchez-Tapias JM, Gatell JM, Mallolas J.

    Hepatology. 2009 Jan;49(1):22-31. Erratum in: Hepatology. 2009 Mar;49(3):1058. PMID: 19085908 [PubMed - indexed for MEDLINE]Related citations

    20.

    The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection.

    Akhan SC, Kalender B, Ruzgar M.

    Infection. 2008 Aug;36(4):341-4. Epub 2008 Jul 15.PMID: 18629437 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk